| (USD) | Jun 2026 | Y/Y change |
|---|---|---|
| Revenue | 129.86M | — |
| Operating expense | — | — |
| Net income | 15.01M | — |
| Net profit margin | — | — |
| Earnings per share | — | — |
| EBITDA | — | — |
| Effective tax rate | — | — |
Over the past year, ARQT returned +56.9% with dividends reinvested.
| Period | Total return |
|---|---|
| YTD | -13.6% |
| 1 year | +56.9% |
| 5 years | +18.5% |
| All-time high | $34.17 (Feb 2021) |
Returns are total returns and include reinvested dividends. The all-time high is the highest monthly closing price on record.
See what $1,000 in ARQT would be worth today ›No. Arcutis Biotherapeutics, Inc. has not paid a dividend in the past 12 months.
Arcutis Biotherapeutics, Inc. stock trades on NASDAQ under the ticker symbol ARQT.
Arcutis Biotherapeutics, Inc. is part of the Healthcare sector.
Arcutis Biotherapeutics, Inc. has a market cap of 3.15B USD, based on the latest quote.
Arcutis Biotherapeutics, Inc. is expected to report earnings around Oct 27, 2026. That date is an estimate and has not been confirmed by the company.
